about
Point-of-Care Testing of Hemostasis in Cardiac SurgeryUsefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary eventsResidual platelet reactivity is associated with clinical and laboratory characteristics in patients with ischemic heart disease undergoing PCI on dual antiplatelet therapyImpact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosisPlatelet function tests: a comparative review.Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis.Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10 + 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet treatment in high-risk vascular patients.A time course study of high on treatment platelet reactivity in acute coronary syndrome male patients on dual antiplatelet therapy.n-3 PUFA supplementation, monocyte PCA expression and interleukin-6 production.eNOS gene influences platelet phenotype in acute coronary syndrome patients on dual antiplatelet treatment.Effect of blood hematocrit and erythrocyte deformability on adenosine 5'-diphosphate platelet reactivity in patients with acute coronary syndromes on dual antiplatelet therapy.Global platelet hyperreactivity and elevated C-reactive protein levels predict long term mortality in STEMI patients.Perioperative assessment of platelet function by Thromboelastograph Platelet Mapping in cardiovascular patients undergoing non-cardiac surgery.Thromboxane inhibition improves renal perfusion and excretory function in severe congestive heart failure.Bioequivalence in the real world is a complex challenge: the case of clopidogrel.Light transmittance aggregometry induced by different concentrations of adenosine diphosphate to monitor clopidogrel therapy: a methodological study.Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents.ADAMTS-13 activity in the presence of elevated von Willebrand factor levels as a novel mechanism of residual platelet reactivity in high risk coronary patients on antiplatelet treatment.Platelet and leukocyte ROS production and lipoperoxidation are associated with high platelet reactivity in Non-ST elevation myocardial infarction (NSTEMI) patients on dual antiplatelet treatment.Evaluation of clotting and fibrinolytic activation after protracted physical exercise.Lipid, inflammatory and haemorheological profiles are significantly affected by farmed fish eating: an intervention study.High platelet turnover and reactivity in renal transplant recipients patients.High on-treatment platelet reactivity by more than one agonist predicts 12-month follow-up cardiovascular death and non-fatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting.Index measured at an intermediate altitude to predict impending acute mountain sicknessResidual platelet reactivity to predict long-term clinical outcomes after clopidogrel loading in patients with acute coronary syndromes: comparison of different cutoff values by light transmission aggregometry from the responsiveness to clopidogrel aCharacterization of Endothelin-1 Receptor Subtypes in Isolated Human CardiomyocytesEndothelin receptors in adult human and swine isolated ventricular cardiomyocytesPlatelet aggregability is modulated by eNOS locus in non-type 2 diabetic patients with acute coronary syndrome☆The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patientsRelationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapyHigh on-treatment platelet reactivity by ADP and increased risk of MACE in good clopidogrel metabolizersDifferent methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patientsEffect of low-dose heparin on fibrinogen levels in patients with chronic ischemic heart diseaseSex related differences in platelet TXA2 generationActivity of dipyrone on intraplatelet arachidonic acid metabolism: An in vitro studyPlasma and serum levels of D-dimer and their correlations with other hemostatic parameters in pregnancyEffect of Temperature and Incubation Time on D-Dimer Serum Levels in Healthy SubjectsEvaluation of a New Point-of-care Celite-activated Clotting Time Analyzer in Different Clinical SettingsEffect of Medium-term Supplementation with a Moderate Dose of n-3 Polyunsaturated Fatty Acids on Blood Pressure in Mild Hypertensive PatientsRadioimmunoassay of thromboxane B2 in plasma: methodological modifications
P50
Q24806594-E1E2ED3A-4649-4387-BFDC-98E24320B122Q28200883-7A9FB212-A6F9-4310-9478-5C90A2F47F45Q28212833-F8343B07-2179-4F85-A68C-A5C069D464CBQ28213327-6F2881C2-0B4B-425B-8568-4A621AA47BDBQ35121464-07E995C8-1CDA-4799-99FE-2F72CD663D9BQ39996910-74677736-D5A5-444D-921D-BDE061ABB8A8Q40154187-834188C6-6C79-400F-BB3E-4A0830C4DAADQ40719450-40D29B08-DFE5-4049-8C2A-C0B68C16DCCEQ42526046-78A9F307-15FE-4061-BC92-D496F32B76A6Q43248056-A121E3FD-C9B9-46F4-BA60-3FE20062A92FQ43280380-71072CEF-576E-4110-A8AB-54B7B1AFD20DQ43498973-69C7FC8C-8EF1-4928-A7EB-789664E6257FQ44221315-C7738CB1-F1BF-4EBC-B1D7-A2EB307A187CQ44505477-EE8F4E10-0B1C-4421-AFDA-7DC795F67CBDQ45717765-8AA9025D-C3F9-46C5-B93C-D18FE1BFD84AQ45733245-974EF48F-90F4-4099-88DE-3335397174C1Q46418076-B6FA1508-C070-4525-B9EB-2A7A1A89F3A3Q46500295-4C469CD3-450B-4C00-B856-2121ABF47F8AQ46968444-3B072B61-A565-4295-9C21-0DA53E4752E0Q47963937-A4ADE14A-0326-4B9B-B175-34656B21CAD4Q48034328-3A2575EE-D0E8-4828-87CA-84C6A6E46B82Q49811587-2BCACCED-147B-41C3-AD5E-CC3750185751Q50059973-B5F5CD77-BDC5-4010-B5B2-A495A8F256F9Q57100026-1C39B6B2-2400-4DF6-8AC1-E2AED0A58F7CQ57764181-E2CA96CA-2117-46EB-B26B-734801D7926FQ58464805-A0B800C1-F3D7-4C84-B383-24C9158FFBB6Q58464813-B99EB348-A0B4-4B1C-B69F-F69D2C63A265Q59402764-A39B721E-A4ED-46DE-A9E3-2C51AC957A68Q59714808-3159482E-0065-47ED-83C6-802431060C6CQ59714818-10C59A93-F09D-49FE-95D7-BC70FAA04DC2Q60678731-89186DFD-7144-4160-BEE5-7D50831F42B2Q60678799-D6022B59-AEDB-45A5-84F4-77884342132BQ60678842-DD46BCA2-2D11-45DF-A9E4-2B56399767D4Q60678870-7F58F38D-DE16-4919-B311-5187C0F669EAQ60678872-265B2B56-9984-4B49-B616-2C3FF4077FF8Q61480574-A98EA99E-82A3-41A3-8060-30E58197DB3FQ61480580-A7A3E342-AE63-4C0D-A98F-15DFB0266CDFQ62607050-B8717FFD-04FF-42B1-BF29-4885F4D7ABA5Q62607057-87228730-6D2A-4745-B62B-AA06782A1712Q67943265-834C33D7-DE4B-4040-91E7-0176E9D209F1
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-7574-8537
@en
name
Rita Paniccia
@ast
Rita Paniccia
@en
Rita Paniccia
@es
Rita Paniccia
@nl
type
label
Rita Paniccia
@ast
Rita Paniccia
@en
Rita Paniccia
@es
Rita Paniccia
@nl
prefLabel
Rita Paniccia
@ast
Rita Paniccia
@en
Rita Paniccia
@es
Rita Paniccia
@nl
P106
P1153
7004370812
P21
P31
P496
0000-0002-7574-8537